Mark Kupersmith, MD
img_Mark Kupersmith
PROFESSOR | Neurology
PROFESSOR | Ophthalmology
PROFESSOR | Neurosurgery
Are you a patient?
Specialties
Neurology, Ophthalmology (Eye), Neuro-Ophthalmology
Research Topics
MRI, Neuroscience, Vision
New topic

I have serve as Chair of the planning committee for NORDIC and directed NORDIC (February 2009-present), fulfilling all of the obligations outlined in NORDIC policies and in the Idiopathic Intracranial Hypertension Treatment Trial, the LIIHTT and for proposed studies, HIS and SiihTT. I intend to continue in the same capacity now as Director of the Enrollment and Resource Centers, administratively integrating studies, sites, investigators, reading centers, Data Coordinating and Biostatistical Center, managing sites and committees and overseeing finance, and scientifically contributing to the multi-site studies conducted across the US and Canada by NORDIC (Neuro-Ophthalmology Research Disease Investigator Consortium).

 

I direct an ECRIP center award at NYEEI, title 'Noninvasive optical imaging detection of changes in the peripapillary retina and optic nerve head due to damage of the optic nerve' which is currently studying glaucoma, optic neuritis, NAION, giant cell arteritis, and NMO. Each project is headed by a 'fellow' who are all subspecialty trained ophthalmologists or neurologists.

MD, Northwestern University Feinberg School of Medicine

Residency, Neurology, NYU Medical Center

Residency, Ophthalmology, NYU Medical Center

Certifications

American Board of Ophthalmology
American Board of Psychiatry and Neurology

New award

Publications

Selected Publications

Ophthalmic and Systemic Factors of Acute Nonarteritic Anterior Ischemic Optic Neuropathy in the Quark207 Treatment Trial. Mark J. Kupersmith, Clare L. Fraser, Rachelle Morgenstern, Neil R. Miller, Leonard A. Levin, Nathalie Jette, Fraser Clare, Chen Celia, Shuey Neil, Colley Stephen, Ningli Wang, Hongliang Dou, Yong Zhong, Luosheng Tang, Quanhong Han, Sandner Dirk, Gamulescu Maria-Andreea, Eter Nicole, Wilhelm Helmut, Lorenz Katrin, Krishna G. Santhosh, Kekunnaya Ramesh, Ambika S, Sharma Kumudini, Vivekanand Uttamrao Warkad, Saxena Rohit, Kumar S. Mahesh, Das Dipankar, Hegade Atul, Mazumdar Shahana, Daighavane Sachin, Sachdeva Virender, Kalish Hadas, Klein Ainat, Huna Baron Ruth, Leiba Hana, Goldenberg Cohen Nitza, Shneck Marina, Kruger Joshua, Ciardella Antonio Pasquale, Virgili Gianni, Carta Arturo, Bianchi Marzoli Stefania, Sharon Tow, Chin Chee Fang, MacIntosh Peter, Bennett Jeffrey, Lam Byron, Katz Bradley, Williams Zoe. Ophthalmology

Classifying and quantifying changes in papilloedema using machine learning. Joseph Branco, Jui Kai Wang, Tobias Elze, Mona K. Garvin, Louis R. Pasquale, Randy Kardon, Brian Woods, David Szanto, Mark J. Kupersmith. BMJ Neurology Open

Hybrid deep learning and optimal graph search method for optical coherence tomography layer segmentation in diseases affecting the optic nerve. Zhi Chen, Honghai Zhang, Edward F. Linton, Brett A. Johnson, Yun J.A.E. Choi, Mark J. Kupersmith, Milan Sonka, Mona K. Garvin, Randy H. Kardon, Jui Kai Wang. Biomedical Optics Express

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kupersmith during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Founder/Co-Founder/Partner

  • SafeTherapeutics, LLC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.